Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2020-01-24 | 2020-02-13 | 104371 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2020-01-30 | 2020-02-13 | 104887 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-04-21 | 2021-06-03 | 137896 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-06-03 | 2021-07-09 | 140360 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-02-17 | 2024-05-09 | 155171 |
| TEVA-FLUTICASONE | 50MCG | METERED-DOSE PUMP | Resolved | 2019-07-02 | 2019-08-06 | 88161 |
| TEVA-FLUTICASONE | 50MCG | METERED-DOSE PUMP | Resolved | 2020-10-01 | 2020-10-15 | 125485 |
| TEVA-FLUTICASONE | 50MCG | METERED-DOSE PUMP | Resolved | 2023-02-16 | 2023-04-28 | 184928 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2017-03-13 | 2017-04-03 | 989 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2017-03-14 | 2017-04-03 | 2301 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2019-01-08 | 2020-04-02 | 71550 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2019-01-08 | 2020-03-19 | 71553 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2020-08-13 | 2021-03-25 | 122208 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195429 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176848 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2021-05-20 | 2021-12-17 | 139731 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2020-10-01 | 2021-04-29 | 125491 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2023-11-03 | 2024-04-25 | 209111 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2022-12-01 | 2024-01-11 | 176851 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Actual shortage | 2024-02-29 | 2024-04-25 | 220983 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |